-

AmerisourceBergen Specialty Group Substitute Notice of Data Incident to Affected Individuals

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Specialty Group (ABSG) is issuing a substitute notice to individuals who may have been impacted by a data security incident. ABSG’s parent company previously announced the data security incident, which is fully contained.

An investigation with the assistance of law enforcement, cybersecurity experts, and outside lawyers has now identified certain individuals whose personal information was involved in the incident. ABSG maintained this information through its previous affiliation with US Bioservices Corp. (US Bio). In some instances, ABSG does not have addresses for the individuals involved. Accordingly, ABSG is issuing this press release. The personal information involved included first name, last name, health insurance information, Medicare/Medicaid number, treatment and prescription information, and date of birth. There is no evidence that any of this information has been or will be publicly disclosed, or that any information was or will be misused for fraudulent purposes as a result of this incident.

For individuals seeking additional information regarding this event, a toll-free assistance line has been established. Individuals may call 1-833-918-6284 toll-free Monday through Friday from 9 am – 9 pm US Eastern Time.

Potentially affected individuals can also find additional information on how they can help protect their personal information, as well as obtain additional resources and other information, by visiting ABSG’s website at https://www.absg.com/usbio

ABSG and its affiliates take this incident and the security of information entrusted to them very seriously. ABSG is working with cybersecurity experts to reinforce its systems and information security protocols in an effort to prevent incidents like this from occurring in the future.

Contacts

Mike Iorfino
610.545.9189
mike.iorfino@cencora.com

AmerisourceBergen Specialty Group


Release Versions

Contacts

Mike Iorfino
610.545.9189
mike.iorfino@cencora.com

More News From AmerisourceBergen Specialty Group

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced investments to enhance its third-party logistics (3PL) capabilities in the United States and Europe, expanding its global network and strengthening the specialty logistics services it can deliver to pharmaceutical companies worldwide. As more specialty pharmaceuticals reach the market and the demand for comprehensive drug supply management continues to increase, Cencora is enhancing its globa...

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global pharmaceutical solutions company, today announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an expanded presence in Alabama and California — will increase Cencora’s capacity, improve efficiency and enhance the resilience of its national distribution network, streng...

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansion, IntrinsiQ is now also offering oncology biomarker data, enabling physicians to transition from a generalized treatment approach to precision medicine. This critical data allows physicians to tailor cancer therapies to the individual needs of e...
Back to Newsroom